Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:382-386
Published online before print December 1, 2003, doi: 10.1161/01.ATV.0000109748.77727.3e
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/2/382    most recent
01.ATV.0000109748.77727.3ev1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collet, J.P.
Right arrow Articles by Weisel, J.W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collet, J.P.
Right arrow Articles by Weisel, J.W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Fibrinolysis
Right arrow Coagulation
Right arrow Fibrinogen/fibrin
Right arrow Coagulation and fibronolysis
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:382.)
© 2004 American Heart Association, Inc.


Thrombosis

Influence of {gamma}' Fibrinogen Splice Variant on Fibrin Physical Properties and Fibrinolysis Rate

J.P. Collet; C. Nagaswami; D.H. Farrell; G. Montalescot; J.W. Weisel

From the Department of Cardiology (J.P.C., G.M.), Pitié-Salpêtrière Hospital, Paris, France (AP-HP); Department of Cell and Developmental Biology (J.P.C., C.N., J.W.W.), University of Pennsylvania School of Medicine, Philadelphia, PA; and Department of Pathology (D.H.F.), Oregon Health & Sciences University, Portland, OR.

Correspondence to J. W. Weisel, Department of Cell and Developmental Biology, University of Pennsylvania, School of Medicine, Philadelphia, PA 19104. E-mail weisel{at}mail.cellbio.upenn.edu

Objective— A splice variant of fibrinogen, {gamma}', has an altered C-terminal sequence in its gamma chain. This {gamma}A/{gamma}' fibrin is more resistant to lysis than {gamma}A/{gamma}A fibrin. Whether the physical properties of {gamma}' and {gamma}A fibrin may account for the difference in their fibrinolysis rate remains to be established.

Methods and Results— Mechanical and morphological properties of cross-linked purified fibrin, including permeability (Ks, in cm2) and clot stiffness (G', in dyne/cm2), were measured after clotting {gamma}A and {gamma}' fibrinogens (1 mg/mL). {gamma}'/{gamma}' fibrin displayed a non-significant decrease in the density of fibrin fibers and slightly thicker fibers than {gamma}A/{gamma}A fibrin (12±2 fiber/10-3nm3 versus 16±2 fiber/10-3nm3 and 274±38 nm versus 257±41 nm for {gamma}'/{gamma}' and {gamma}A/{gamma}A fibrin, respectively; P=NS). This resulted in a 20% increase of the permeability constant (6.9±1.7 10-9 cm2 versus 5.5±1.9 10-9 cm2, respectively; P=NS). Unexpectedly, {gamma}' fibrin was found to be 3-times stiffer than {gamma}A fibrin (72.6±2.6 dyne/cm2 versus 25.1±2.3 dyne/cm2; P<0.001). Finally, there was a 10-fold decrease of the fibrin fiber lysis rate.

Conclusions— Fibrinolysis resistance that arises from the presence of {gamma}A/{gamma}' fibrinogen in the clot is related primarily to an increase of fibrin cross-linking with only slight modifications of the clot architecture.


Key Words: coagulation • fibrin • fibrinogen • fibrinolysis • thrombosis




This article has been cited by other articles:


Home page
BloodHome page
S. Uitte de Willige, K. F. Standeven, H. Philippou, and R. A. S. Ariens
The pleiotropic role of the fibrinogen {gamma}' chain in hemostasis
Blood, November 5, 2009; 114(19): 3994 - 4001.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. A. Smith and J. H. Morrissey
Polyphosphate enhances fibrin clot structure
Blood, October 1, 2008; 112(7): 2810 - 2816.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. A. Dugan, V. W.-C. Yang, D. J. McQuillan, and M. Hook
Decorin Modulates Fibrin Assembly and Structure
J. Biol. Chem., December 15, 2006; 281(50): 38208 - 38216.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Silveira and A. Hamsten
Fibrin gel architecture influences endogenous fibrinolysis and may promote coronary artery disease.
Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2419 - 2420.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J.P. Collet, Y. Allali, C. Lesty, M.L. Tanguy, J. Silvain, A. Ankri, B. Blanchet, R. Dumaine, J. Gianetti, L. Payot, et al.
Altered Fibrin Architecture Is Associated With Hypofibrinolysis and Premature Coronary Atherothrombosis
Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2567 - 2573.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. R. Siebenlist, M. W. Mosesson, I. Hernandez, L. A. Bush, E. Di Cera, J. R. Shainoff, J. P. Di Orio, and L. Stojanovic
Studies on the basis for the properties of fibrin produced from fibrinogen-containing {gamma}' chains
Blood, October 15, 2005; 106(8): 2730 - 2736.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Hamsten, M. N. Mannila, and A. Silveira
Quest for Genes Regulating Plasma Fibrinogen Concentration: Still a Long Way to Go
Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1100 - 1101.
[Full Text] [PDF]